A live demonstration of Affera's technology by specialists Vivek Reddy, MD, and Petr Neuzil, MD, PhD. Footage courtesy of Affera/Medtronic.
Affera’s portfolio includes interventional solutions such as the Affera Prism-1 mapping and navigation platform, designed to help electrophysiologists diagnose heart rhythm issues, and the Sphere-9 cardiac ablation catheter.
An Evolut TAVR valve from Medtronic (left) and a Sapien 3 TAVR valve from Edwards Lifesciences (right).
The standard-of-care thinking on TAVR has shifted from getting a valve implanted and managing immediate complications to looking decades down the road and considering the patient's long-term health.
Christine Albert, MD, MPH. Image courtesy of the Smidt Heart Institute at Cedars-Sinai Medical Center.
New research, published in JAMA Cardiology, challenges the common belief that AFib is more likely to develop among men than women. The key problem, it seems, is that prior research teams did not understand the significance of certain risk factors.
The Federal Food and Drug Administration (FDA) has amended its emergency use authorizations (EUAs) to include updated booster shots targeting the BA.4 and BA.5 COVID-19 subvariants.
Mammography practices need to continue supporting pre-Digital Age channels for patients to schedule appointments, participate in community health programs and receive annual screening exams in mobile settings close to where they live.
Researchers suggested that the quantitative measures derived from synthetic MRI exams could be used to help guide treatment decisions for breast cancer patients.